Literature DB >> 17355838

Trigeminal autonomic cephalalgias: diagnosis and treatment.

Peter J Goadsby1, Anna S Cohen, Manjit S Matharu.   

Abstract

The trigeminal autonomic cephalalgias (TACs) are a group of primary headache disorders characterized by unilateral head pain that occurs in association with ipsilateral cranial autonomic features. The TACs include cluster headache, paroxysmal hemicrania, and short-lasting unilateral neuralgiform headache attacks with conjunctival injection and tearing (SUNCT) and its close relative short-lasting unilateral neuralgiform headache attacks with cranial autonomic symptoms (SUNA). These syndromes cause patients considerable disability and certainly very significant suffering. They are distinguished by the frequency of attacks of pain, the length of the attacks, and very characteristic responses to medical therapy, such that the diagnosis can usually be made clinically, which is important because it completely dictates therapy. The management of TACs can be very rewarding for physicians and highly beneficial to patients.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17355838     DOI: 10.1007/s11910-007-0006-6

Source DB:  PubMed          Journal:  Curr Neurol Neurosci Rep        ISSN: 1528-4042            Impact factor:   5.081


  64 in total

1.  Chronic paroxysmal hemicrania presenting as otalgia with a sensation of external acoustic meatus obstruction: two cases and a pathophysiologic hypothesis.

Authors:  C J Boes; J W Swanson; D W Dodick
Journal:  Headache       Date:  1998 Nov-Dec       Impact factor: 5.887

2.  Verapamil in the prophylaxis of episodic cluster headache: a double-blind study versus placebo.

Authors:  M Leone; D D'Amico; F Frediani; F Moschiano; L Grazzi; A Attanasio; G Bussone
Journal:  Neurology       Date:  2000-03-28       Impact factor: 9.910

Review 3.  Chronic paroxysmal hemicrania (CPH): a review of the clinical manifestations.

Authors:  F Antonaci; O Sjaastad
Journal:  Headache       Date:  1989-11       Impact factor: 5.887

4.  Prophylactic treatment of cluster headache with verapamil.

Authors:  I J Gabai; E L Spierings
Journal:  Headache       Date:  1989-03       Impact factor: 5.887

5.  The clinical characteristics of headache in patients with pituitary tumours.

Authors:  M J Levy; M S Matharu; K Meeran; M Powell; P J Goadsby
Journal:  Brain       Date:  2005-05-11       Impact factor: 13.501

6.  A review of paroxysmal hemicranias, SUNCT syndrome and other short-lasting headaches with autonomic feature, including new cases.

Authors:  P J Goadsby; R B Lipton
Journal:  Brain       Date:  1997-01       Impact factor: 13.501

7.  Parenteral indomethacin (the INDOTEST) in cluster headache.

Authors:  F Antonaci; A Costa; S Ghirmai; G Sances; O Sjaastad; G Nappi
Journal:  Cephalalgia       Date:  2003-04       Impact factor: 6.292

8.  Chronic paroxysmal hemicrania and hemicrania continua: anaesthetic blockades of pericranial nerves.

Authors:  F Antonaci; J A Pareja; A B Caminero; O Sjaastad
Journal:  Funct Neurol       Date:  1997 Jan-Feb

Review 9.  The trigeminovascular system in humans: pathophysiologic implications for primary headache syndromes of the neural influences on the cerebral circulation.

Authors:  A May; P J Goadsby
Journal:  J Cereb Blood Flow Metab       Date:  1999-02       Impact factor: 6.200

10.  Sumatriptan in chronic cluster headache: results of continuous treatment for eleven months.

Authors:  K Ekbom; E Waldenlind; J Cole; A Pilgrim; A Kirkham
Journal:  Cephalalgia       Date:  1992-08       Impact factor: 6.292

View more
  9 in total

Review 1.  Emerging relevance of circadian rhythms in headaches and neuropathic pain.

Authors:  Mark J Burish; Zheng Chen; Seung-Hee Yoo
Journal:  Acta Physiol (Oxf)       Date:  2018-07-25       Impact factor: 6.311

Review 2.  Ocular and orbital pain for the headache specialist.

Authors:  Alexander L Ringeisen; Andrew R Harrison; Michael S Lee
Journal:  Curr Neurol Neurosci Rep       Date:  2011-04       Impact factor: 5.081

3.  Cluster headache or giant cell arteritis?

Authors:  Sangeetha Baskar; Rolland Etti; George Kitas; Rainer Klocke
Journal:  BMJ Case Rep       Date:  2008-11-20

4.  Management of cluster headache.

Authors:  Peer C Tfelt-Hansen; Rigmor H Jensen
Journal:  CNS Drugs       Date:  2012-07-01       Impact factor: 5.749

Review 5.  Evidence-based treatments for cluster headache.

Authors:  Rubesh Gooriah; Alina Buture; Fayyaz Ahmed
Journal:  Ther Clin Risk Manag       Date:  2015-11-09       Impact factor: 2.423

6.  Reference programme: diagnosis and treatment of headache disorders and facial pain. Danish Headache Society, 2nd Edition, 2012.

Authors:  Lars Bendtsen; Steffen Birk; Helge Kasch; Karen Aegidius; Per Schmidt Sørensen; Lise Lykke Thomsen; Lars Poulsen; Mary-Jette Rasmussen; Christina Kruuse; Rigmor Jensen
Journal:  J Headache Pain       Date:  2012-02       Impact factor: 7.277

7.  Minimal adverse effects profile following implantation of periauricular percutaneous electrical nerve field stimulators: a retrospective cohort study.

Authors:  Arthur Roberts; Alec Sithole; Marcos Sedghi; Charles A Walker; Theresa M Quinn
Journal:  Med Devices (Auckl)       Date:  2016-11-03

Review 8.  The development and validation of the Cluster Headache Quality of life scale (CHQ).

Authors:  Norazah Abu Bakar; Mariam Torkamani; Surat Tanprawate; Giorgio Lambru; Manjit Matharu; Marjan Jahanshahi
Journal:  J Headache Pain       Date:  2016-09-05       Impact factor: 7.277

Review 9.  Orofacial pain management: current perspectives.

Authors:  Marcela Romero-Reyes; James M Uyanik
Journal:  J Pain Res       Date:  2014-02-21       Impact factor: 3.133

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.